C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Clinical trial NCT00292981 · COMPLETED

Trial details

NCT number: NCT00292981
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2005-08-01
Primary completion: 2010-02-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.